SALT LAKE CITY, May 05, 2020 (GLOBE NEWSWIRE) — ClearOne (NASDAQ: CLRO), a leading global provider of audio and visual communication solutions, today comments on the Report and Recommendation issued by the Honorable Christopher J. Burke of the U.S. District Court of Delaware recommending the denial of Shure Incorporated’s (“Shure’s”) emergency motion for a temporary restraining order (“Motion”) to stop the sale of ClearOne’s innovative Huddle-compatible Ceiling Tile Beamforming Array (“BMA CTH”) products.
In November 2019, ClearOne announced its COLLABORATE® Versa Pro CT product offering, which combines the BMA CTH with the CONVERGE® Huddle audio DSP to provide superior functionality and audio quality for small- to medium-sized rooms. ClearOne began selling this product offering in December 2019. Then, in February 2020, ClearOne announced the COLLABORATE Versa Room CT and Versa Lite CT product offerings, which also include the BMA CTH and require no external DSP. ClearOne anticipates sales of these product offerings to begin later this quarter.
On April 14, during a worldwide pandemic, Shure filed an emergency Motion to stop ongoing and future sales of ClearOne’s BMA CTH products. Shure’s Motion asserted baseless design patent infringement claims against ClearOne’s innovative BMA CTH products and argued that Shure will be irreparably harmed by having to compete with those products. Judge Burke swiftly rejected Shure’s Motion, holding that Shure had failed to show that it would suffer irreparable harm in the absence of injunctive relief and that ClearOne had raised a “substantial question” as to the validity of the patent Shure asserts against ClearOne, D865,723 (the “’723 patent”). […]